Valuation: INSTITUT

Market Cap 4.4B 52.57M 46.62M 43.45M 39.61M 74.79M 5.05B 75.42M 527M 204M 2.56B 197M 193M 8.27B P/E 2024
25.7x
P/E 2025 46.2x
Enterprise Value 4.64B 55.37M 49.1M 45.77M 41.72M 78.78M 5.32B 79.43M 555M 215M 2.7B 208M 203M 8.71B EV / Sales 2024
3.02x
EV / Sales 2025 2.7x
Free-Float
17.07%
Yield 2024 *
-
Yield 2025 2.02%
Manager TitleAgeSince
Chief Executive Officer - -
Director of Finance/CFO - -
Chief Investment Officer - -
Director TitleAgeSince
Director/Board Member 68 23/08/2010
Director/Board Member 47 09/01/2014
Director/Board Member 45 01/01/2011
Change 5-day change 1-year change 3-year change Capi.($)
+1.48%-3.00%+11.58%+24.85% 111B
+0.78%-2.05%-0.66%+74.89% 92.38B
+0.46%-0.54%+145.20%+833.67% 59.15B
-0.38%-5.45%-7.47%+54.41% 27.66B
+0.97%-1.27%+30.11%+92.79% 25.75B
+1.28%-0.37%+11.39%+53.88% 25.02B
-0.67%-0.58%-16.34%-7.26% 20.99B
+1.83%-0.42%+27.40%+309.14% 20.82B
+1.30%-2.86%-4.06%+34.25% 16.87B
Average +0.78%-1.81%+21.90%+163.40% 44.36B
Weighted average by Cap. +0.89%-2.04%+27.10%+178.05%

Financials

2024 2025
Net sales 1.52B 18.17M 16.12M 15.02M 13.69M 25.86M 1.75B 26.07M 182M 70.59M 885M 68.12M 66.75M 2.86B 1.72B 20.5M 18.18M 16.94M 15.45M 29.16M 1.97B 29.41M 206M 79.62M 998M 76.84M 75.29M 3.22B
Net income 215M 2.57M 2.28M 2.12M 1.93M 3.65M 247M 3.68M 25.74M 9.97M 125M 9.62M 9.43M 404M 96.95M 1.16M 1.03M 957K 873K 1.65M 111M 1.66M 11.61M 4.5M 56.36M 4.34M 4.25M 182M
Net Debt 199M 2.38M 2.11M 1.97M 1.79M 3.39M 229M 3.41M 23.86M 9.24M 116M 8.92M 8.74M 374M 234M 2.8M 2.48M 2.32M 2.11M 3.99M 269M 4.02M 28.09M 10.88M 136M 10.5M 10.29M 440M
Logo INSTITUT
Artgen Biotekh PAO is a Russia-based company engaged in the research and development and invesment in biotechnology. The Company develops and implements drugs, products or methods of treatment, diagnostic and prevention of diseases. The Company invests in assets engaged in development and commercialization of new drugs, medical devices, genetic diagnostics and research and other high-tech products and services related to biomedicine and healthcare. Artgen Biotekh PAO develops a platform for startups and companies to share knowledge related to science, research, production, marketing, business, regulations, patent and other fields. Some of the Company's products are Neovasculgen, a gene therapy drug, vaccines Tetraflubet and Betuvax and others.
Employees
-